Cite
HARVARD Citation
Wagner, M. et al. (2014). Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada. Canadian journal of infectious diseases & medical microbiology =. 25 (2), pp. 87-94. [Online].